TORONTO, Sept. 14, 2012 /CNW/ - Prism Medical Ltd., ("Prism" or "the
Company") (TSXV: PM), a leading provider of durable medical equipment
and related services to the mobility disadvantaged, announced today
that it granted options on September 14, 2012 to certain senior
officers and employees to acquire 180,000 common shares exercisable at
a price of $6.05 per share for a period of five years. The options vest
25% on each of the first four anniversary dates of the grant, and are
otherwise subject to the terms of Prism's stock option plan.
About Prism Medical Ltd.
Prism Medical Ltd. is one of the largest providers and manufacturers of
durable medical equipment and related services to the mobility
challenged in Canada, the US and the UK, with more than 100,000
installations and 200,000 product solutions sold. The Prism Medical
brands include Waverley Glen and ErgoSafe, North America's leading
supplier of lifting, handling and repositioning aid products and
services across Canada and the US Freeway and Prism Service & Repair
are leading suppliers of moving and handling products and services in
the UK. For further information visit Prism Medical's website at www.prismmedicalltd.com or www.sedar.com.
This document contains forward‐looking statements relating to our
operations and to the environment in which we operate and our strategy,
action plans and investments, which may involve estimates, forecasts
and projections. These statements are not guarantees of future
performance and involve risks and uncertainties that are difficult to
predict and/or are beyond our control. A number of important factors
could cause actual outcomes and results to differ materially from those
expressed in these forward‐looking statements. These factors include
those set forth in this report and our other public filings.
Consequently, readers should not place any undue reliance on such
forward‐looking statements. These forward‐looking statements are made
as of the date of this report. Prism Medical is under no obligation to
update any forward‐looking statements contained herein should material
facts change due to new information, future events or other factors.
All forward‐looking statements attributable to Prism Medical are
expressly qualified by these cautionary statements.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
SOURCE: Prism Medical Ltd.
For further information:
Chief Financial Officer
416-260-2145 ext. 229
416-815-0700 ext. 264